<DOC>
	<DOCNO>NCT02159352</DOCNO>
	<brief_summary>The purpose study determine whether multiple dos darunavir/ritonavir lopinavir/ritonavir affect pharmacokinetics daclatasvir healthy participant .</brief_summary>
	<brief_title>Study Assessing Effects Darunavir/Ritonavir Lopinavir/Ritonavir Pharmacokinetics Daclatasvir Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Darunavir</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Key Healthy male female participant , age 18 49 , determine medical history , physical examination , 12 lead electrocardiogram , vital sign , clinical laboratory evaluation Key Any significant acute chronic medical illness ; donation blood blood bank clinical study ( except screen visit ) within 4 week study drug administration ( within 2 week plasma ) ; blood screen finding positive hepatitis C antibody , hepatitis B surface antigen , HIV1 HIV2 antibody</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>